Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2025-12-25 @ 2:47 AM
NCT ID:
NCT06241833
Eligibility Criteria:
Inclusion Criteria:
* \- PCI with MI (I21) admission
* Age more than 40 or less than 80 years old
* Aspirin and Clopidogrel/Prasugrel/Ticagrelor prescription with more than 2 days at discharge
Exclusion Criteria:
* \- Previous use of a PPI, an H2-receptor antagonist, sucralfate, or misoprostol within 30 days before admission
* Preexisting cancer within a year before admission
* History of RBC transfusion
* RBC transfusion in admission
* Cardiogenic Shock
* Length of stay more than 14 days
* OAC prescription with more than 2 days at discharge
* H2 prescription with more than 2 days at discharge
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT06241833
Study Brief:
Protocol Section:
NCT06241833